tradingview
Weekly Recap: Nemluvio regulatory expansion and Alastin JPAC roll-out
Galderma Group AG (SIX:GALD) is accelerating international expansion—advancing Nemluvio filings, rolling out Alastin across JPAC with Taiwan live and Japan, Singapore and South Korea launches planned, while preparing product lifecycles and joining the Swiss Market Index on Sept 21, 2026.Previous We…